Barinthus Biotherapeutics plc Files 8-K
Ticker: BRNS · Form: 8-K · Filed: Jun 10, 2025 · CIK: 1828185
| Field | Detail |
|---|---|
| Company | Barinthus Biotherapeutics PLC. (BRNS) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: VACC
TL;DR
Barinthus (VACC) filed an 8-K for a shareholder vote. Big stuff coming.
AI Summary
On June 10, 2025, Barinthus Biotherapeutics plc. filed an 8-K report indicating a submission of matters to a vote of security holders. The company, formerly known as Vaccitech plc, is incorporated in England and Wales and operates in the pharmaceutical preparations industry.
Why It Matters
This filing signals that Barinthus Biotherapeutics plc is proceeding with important corporate actions requiring shareholder approval, which could impact the company's future direction and value.
Risk Assessment
Risk Level: low — The filing is a standard procedural report regarding a vote of security holders and does not disclose any immediate financial or operational risks.
Key Players & Entities
- Barinthus Biotherapeutics plc (company) — Registrant
- Vaccitech plc (company) — Former company name
- June 10, 2025 (date) — Date of report
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters to be voted on, only that it is a 'Submission of Matters to a Vote of Security Holders'.
When was Barinthus Biotherapeutics plc formerly known as Vaccitech plc?
The company's name change from Vaccitech plc to Barinthus Biotherapeutics plc occurred on April 7, 2021.
What is the primary business of Barinthus Biotherapeutics plc?
Barinthus Biotherapeutics plc is classified under Pharmaceutical Preparations (SIC code 2834).
In which jurisdiction is Barinthus Biotherapeutics plc incorporated?
The company is incorporated in England and Wales.
What is the SEC file number for Barinthus Biotherapeutics plc?
The SEC file number for Barinthus Biotherapeutics plc is 001-40367.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding Barinthus Biotherapeutics plc. (BRNS).